49 related articles for article (PubMed ID: 25973068)
1. Evaluation of Elafin Immunohistochemical Expression as Marker of Cervical Cancer Severity.
Longatto-Filho A; Fregnani JH; Mafra da Costa A; de Araujo-Souza PS; Scapulatempo-Neto C; Herbster S; Boccardo E; Termini L
Acta Cytol; 2021; 65(2):165-174. PubMed ID: 33271565
[TBL] [Abstract][Full Text] [Related]
2. Leucine-rich repeat-containing G protein-coupled receptor 5 expression in lymph node metastases of colorectal cancer: Clinicopathological insights and prognostic implications.
Sawaguchi H; Uehara T; Iwaya M; Asaka S; Nakajima T; Kamakura M; Nagaya T; Yoshizawa T; Ota H; Umemura T
Pathol Int; 2024 May; ():. PubMed ID: 38787285
[TBL] [Abstract][Full Text] [Related]
3. A conditional transgenic mouse line for targeted expression of the stem cell marker LGR5.
Norum JH; Bergström Å; Andersson AB; Kuiper RV; Hoelzl MA; Sørlie T; Toftgård R
Dev Biol; 2015 Aug; 404(2):35-48. PubMed ID: 26003047
[TBL] [Abstract][Full Text] [Related]
4. Clinical Implications and Prognostic Value of Leucine-Rich G Protein-Coupled Receptor 5 Expression as A Cancer Stem Cell Marker in Malignancies: A Systematic Review and Meta-Analysis.
Ghobakhloo S; Khoshhali M; Vatandoost N; Jafarpour S; Niazmand A; Nedaeinia R; Salehi R
Cell J; 2024 Jan; 26(1):1-12. PubMed ID: 38351725
[TBL] [Abstract][Full Text] [Related]
5.
Nishioka M; Suehiro Y; Sakai K; Matsumoto T; Okayama N; Mizuno H; Ueno K; Suzuki N; Hashimoto S; Takami T; Hazama S; Nagano H; Sakaida I; Yamasaki T
Oncol Lett; 2018 Apr; 15(4):5989-5994. PubMed ID: 29556315
[TBL] [Abstract][Full Text] [Related]
6. LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.
Cao HZ; Liu XF; Yang WT; Chen Q; Zheng PS
Cell Death Dis; 2017 Sep; 8(9):e3039. PubMed ID: 28880275
[TBL] [Abstract][Full Text] [Related]
7. Loss of Keratin 17 induces tissue-specific cytokine polarization and cellular differentiation in HPV16-driven cervical tumorigenesis in vivo.
Hobbs RP; Batazzi AS; Han MC; Coulombe PA
Oncogene; 2016 Oct; 35(43):5653-5662. PubMed ID: 27065324
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and Prognostic Significance of c-Met in Cervical Cancer: A Meta-Analysis.
Peng J; Qi S; Wang P; Li W; Liu C; Li F
Dis Markers; 2016; 2016():6594016. PubMed ID: 27069297
[TBL] [Abstract][Full Text] [Related]
9. Lgr5 is a potential prognostic marker in patients with cervical carcinoma.
Sun B; Ye X; Li Y; Zhang W
Int J Clin Exp Pathol; 2015; 8(2):1783-9. PubMed ID: 25973068
[TBL] [Abstract][Full Text] [Related]
10. Stomatin-like protein 2 expression is associated with clinical survival in patients with cervical cancer.
Xiao B; Xie Z; Guo L; Wu J; Zhang H
Int J Clin Exp Pathol; 2015; 8(2):1804-9. PubMed ID: 25973071
[TBL] [Abstract][Full Text] [Related]
11. Wnt5A expression is associated with the tumor metastasis and clinical survival in cervical cancer.
Lin L; Liu Y; Zhao W; Sun B; Chen Q
Int J Clin Exp Pathol; 2014; 7(9):6072-8. PubMed ID: 25337253
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
Hazelbag S; Kenter GG; Gorter A; Fleuren GJ
Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
